Edward J. Benz Jr.
CIK: 0001691160
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CADL
Candel Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Benz Edward J. JR
Benz Edward J. JR (SEC CIK 0001691160) files insider reports with the SEC as Director of Candel Therapeutics, Inc. (CADL).
Signal8 holds 2 ownership filings by Benz Edward J. JR, all Form 4s, filed between Jun 18, 2025 and Jun 24, 2026. Those filings report 2 transactions, from Jun 17, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Benz Edward J. JR's filings is in NEEDHAM, MA.
Recent filings by Benz Edward J. JR
Other insiders filing for Candel Therapeutics, Inc. (CADL)
- Loggia Nicoletta, Director
- PAPA JOSEPH C, Director
- Manning Paul B, Director
- Tak Paul Peter, Chief Executive Officer
- Zimmermann Martine, Director
- Tyagarajan Seshu, Chief Technology Officer